(Q42844975)

8 November 2017

Adalimumab: a new modality for Behçet's disease? (English)

1 reference

8 November 2017

0 references

0 references

J A M van Laar

1

1 reference

8 November 2017

T Missotten

2

1 reference

8 November 2017

P L A van Daele

3

1 reference

8 November 2017

A Jamnitski

4

1 reference

8 November 2017

G S Baarsma

5

1 reference

8 November 2017

P M van Hagen

6

1 reference

8 November 2017

language of work or name

English

0 references

publication date

23 November 2006

1 reference

Annals of the Rheumatic Diseases

8 November 2017

1 reference

8 November 2017

66

1 reference

8 November 2017

4

1 reference

8 November 2017

565-566

1 reference

[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication]

8 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Current concepts in the etiology and treatment of Behçet disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Anti-TNF-alpha therapy for sight threatening uveitis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856047

16 August 2018

Identifiers

DOI

10.1136/ARD.2006.064279

1 reference

8 November 2017

1 reference

8 November 2017

1 reference